Este sitio web utiliza tecnologías de seguimiento, como cookies, para brindar una mejor experiencia al usuario. Si continúa utilizando este sitio, entonces reconoce nuestro uso de tecnologías de seguimiento. Para obtener información adicional, consulte nuestra Política de Privacidad.
REGÍSTRESE
Autophagy is a cellular degradation pathway that, when it occurs in cancer cells, can impact the growth and behavior of the resulting tumor. The precise effects of stromal autophagy—as well as how they are mediated—are not well understood, though. Dr. Hillary Coller has developed a novel model that allows her to investigate how stromal autophagy affects the interactions between different cell types within the tumor environment. Specifically, she’s investigating how autophagy in the stroma might influence the response to immunotherapy. These insights could then potentially be used to develop complementary therapies that make immunotherapy more effective and improve patient survival.
University of California, Los Angeles | All Cancers, Melanoma | 2017
Comuníquese con nosotros
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Directorio de Personal
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).